Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Ohio Board of Nursing Proposes Rule Changes for Nurses

Client Alert
January 14, 2026

On Monday, January 12, 2026, the Ohio Board of Nursing released a package of proposed changes to the Ohio Administrative Code.  While most of the rules had no proposed changes or merely proofreading changes, there was one rule change that will be of significant interest to our LPN, RN, and APRN clients.

Ohio Board of Nursing Proposed Rule Changes - a medical professional's arm holding a stethescope.

OAC 4723-14-01 sets forth definitions related to continuing education (CE) requirements.  There are two proposed changes that Ohio nurses should be watching. 

First, under Section (E), the definition for “Category A” credits would be adjusted to allow for CE credits that may be offered by an approved organization that is not headquartered in Ohio.  This may expand a nurse’s CE opportunities. 

Second, under Section (U), the “Reporting Period” definition would be adjusted.  LPNs, RNs, and APRNs would now have a reporting period of July 1 – June 30 in odd numbered years.  (The current reporting period is November through October.)  If this change is adopted, nurses will want to be aware, so that they don’t miss any deadlines. 

As a reminder, proposed changes to the Ohio Administrative Code trigger a public hearing.  As such, If you or your organization wish to submit comments or give testimony on any of the proposed rules discussed herein, please note that there is a hearing scheduled for February 13, 2026.

If you would like assistance with laws governing Ohio’s nurses or in preparing comments on potential regulatory changes, please contact BMD Health Law Group member, Jeana Singleton at jmsingleton@bmdllc.com or 330-253-2001. 

 

Ohio Board of NursingHealthcareHealth Law
Client Alert

CMS Requires Providers to Use an Updated Advance Beneficiary Notice (ABN) Form by May 12, 2026

May 22, 2026CMS has released an updated Advance Beneficiary Notice of Noncoverage (ABN), Form CMS-R-131, that all providers and suppliers must begin using by May 12, 2026. The revised form includes clearer language and formatting updates intended to improve patient understanding and compliance.Client Alert

CMS and Ohio Ramp Up Fraud Enforcement in Home Health and Hospice

May 15, 2026CMS and Ohio have launched sweeping new fraud prevention initiatives targeting home health and hospice providers, signaling a period of heightened scrutiny for enrollment, billing, documentation, and EVV compliance. While aimed at combating fraud, these measures also create significant operational and due process risks for compliant agencies, making proactive compliance programs, auditing, and governance more important than ever.Client Alert

MYTH BUSTER: Can a New Chiropractor Bill Under An Established Chiropractor’s NPI?

May 14, 2026Many chiropractic practices mistakenly believe a newly hired chiropractor can bill under an established chiropractor’s NPI while waiting for credentialing approval. In most cases, this is not permitted. Claims should be submitted under the NPI of the chiropractor who actually rendered the service to avoid compliance risks, including potential False Claims Act exposure. This article outlines key billing rules, common exceptions, and practical compliance tips for chiropractic practices.Client Alert

RNs and APRNs Take Note: Ohio Board of Nursing Mandates a New CE Reporting Period

April 29, 2026Ohio’s Board of Nursing has updated the continuing education reporting period for RNs and APRNs. Beginning March 26, 2026, CE credits must be completed between July 1 and June 30 of odd-numbered years, replacing the previous November to October timeframe.Client Alert

Ohio Med Spas: Peptide Do's and Do Not's

April 29, 2026Recent guidance from the Ohio Board of Pharmacy outlines key compliance requirements for med spas using peptides. While some peptide drugs are FDA approved, others are not or cannot be compounded. Med spa operators should ensure they source medications from licensed suppliers, avoid non-approved or “research use only” products, and follow all compounding and storage regulations to maintain compliance and avoid enforcement actions.
Older posts